Epigenomics in Collaborative Effort to Develop Colorectal Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Epigenomics is collaborating with German researchers on the development of a new blood-based molecular diagnostic test for detecting colorectal cancer, as well as pre-malignant precursors of the disease, the firm said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.